XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Notes Payable
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Notes Payable
Common Stock
Class B Common Stock
Additional 
Paid-in 
Capital
Additional 
Paid-in 
Capital
Notes Payable
Accumulated 
Other 
Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022     2,347,276   266,670        
Beginning balance at Dec. 31, 2022 $ 200,992   $ 0   $ 0 $ 3,724,242   $ 3,505 $ (3,526,755)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)       3,363,291          
Conversion of notes payable and accrued interest into Class A Common Stock   $ 283,108         $ 283,108    
Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange (6,811)         (6,811)      
Reclassification of February 28, 2023 earnout shares liability to equity due to authorized share increase 5,014         5,014      
Reclassification of February 28, 2023 stock-based awards liability to equity due to authorized share increase 8,978         8,978      
Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares (2,112)         (2,112)      
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares (2,979)         (2,979)      
Stock-based compensation 4,624         4,624      
Exercise of warrants (in shares)     213,037            
Exercise of warrants 51,276         51,276      
Exercise of stock options (in shares)     207            
Exercise of stock options 44         44      
Issuance of shares for RSU vesting net of tax withholdings (in shares)     9,521            
Issuance of shares for RSU vesting net of tax withholdings (100)         (100)      
Foreign currency translation adjustment 5,567             5,567  
Net loss (269,901)               (269,901)
Ending balance (in shares) at Jun. 30, 2023     5,932,301   266,670        
Ending balance at Jun. 30, 2023 277,700   $ 0   $ 0 4,065,284   9,072 (3,796,656)
Beginning balance (in shares) at Dec. 31, 2022     2,347,276   266,670        
Beginning balance at Dec. 31, 2022 200,992   $ 0   $ 0 3,724,242   3,505 (3,526,755)
Ending balance (in shares) at Dec. 31, 2023     42,433,025   266,670        
Ending balance at Dec. 31, 2023 228,236   $ 4   $ 0 4,180,869   5,862 (3,958,499)
Beginning balance (in shares) at Mar. 31, 2023     3,495,303   266,670        
Beginning balance at Mar. 31, 2023 255,777   $ 0   $ 0 3,924,555   2,950 (3,671,728)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)       2,431,875          
Conversion of notes payable and accrued interest into Class A Common Stock   144,928         144,928    
Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares (2,112)         (2,112)      
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares (2,979)         (2,979)      
Stock-based compensation 993         993      
Issuance of shares for RSU vesting net of tax withholdings (in shares)     6,154            
Cancellations (in shares)     (1,031)            
Cancellations (101)         (101)      
Foreign currency translation adjustment 6,122             6,122  
Net loss (124,928)               (124,928)
Ending balance (in shares) at Jun. 30, 2023     5,932,301   266,670        
Ending balance at Jun. 30, 2023 277,700   $ 0   $ 0 4,065,284   9,072 (3,796,656)
Beginning balance (in shares) at Dec. 31, 2023     42,433,025   266,670        
Beginning balance at Dec. 31, 2023 228,236   $ 4   $ 0 4,180,869   5,862 (3,958,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)       398,819,335          
Conversion of notes payable and accrued interest into Class A Common Stock   75,826   $ 40     75,786    
Reverse stock split related round up share issuances (in shares)     12,266            
Stock-based compensation 658         658      
Foreign currency translation adjustment 864             864  
Net loss (156,902)               (156,902)
Ending balance (in shares) at Jun. 30, 2024     441,264,626   266,670        
Ending balance at Jun. 30, 2024 148,682   $ 44   $ 0 4,257,313   6,726 (4,115,401)
Beginning balance (in shares) at Mar. 31, 2024     159,390,384   266,670        
Beginning balance at Mar. 31, 2024 201,519   $ 16   $ 0 4,202,125   6,094 (4,006,716)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)       281,874,242          
Conversion of notes payable and accrued interest into Class A Common Stock   $ 55,099   $ 28     $ 55,071    
Stock-based compensation 117         117      
Foreign currency translation adjustment 632             632  
Net loss (108,685)               (108,685)
Ending balance (in shares) at Jun. 30, 2024     441,264,626   266,670        
Ending balance at Jun. 30, 2024 $ 148,682   $ 44   $ 0 $ 4,257,313   $ 6,726 $ (4,115,401)